1 SPCTRM Stanford/Packard Center for Translational Research in Medicine SARP Meeting 7/24/08 Study Budgeting Anna Hu, RN, MPH Stanford University School.

Slides:



Advertisements
Similar presentations
Budgeting for Clinical Trials
Advertisements

Building A Clinical Trial Budget The Vanderbilt Way Lynda Lane, MS, RN Administrative Director, GCRC.
The Diabetic Retinopathy Clinical Research Network
CBER Isolagen Therapy (IT) BLA FDA Clinical Review Agnes Lim, MD Yao-Yao Zhu, MD, PhD DCEPT/OCTGT/CBER, FDA October 9, 2009 Advisory Committee Meeting.
David Cloutier Director, Research Center Management and Development Budgeting for Industry Sponsored Clinical Trials.
Clinical Research Billing Schedule workflow
Identification & Distinction of Clinical Trial Participant Charges Bethany Martell Office of Clinical Research Associate Director- Financial Operations.
Determining % Effort for Clinical Trial Kathy Price, RN, MBA Manager, GI Clinical Research.
Brookhaven Science Associates U.S. Department of Energy 1 Brookhaven National Laboratory Protocol Compliance Monitoring Darcy Mallon May 7, 2009.
PRE-AWARD PAPERWORK FOR CLINICAL TRIALS SERIES 4, SESSION 8 OCTOBER 28, 2014 Applicants and Administrators Pre-Award Luncheon Series.
Clinical Pharmacy’s Role in Research Trials Sheree Miller Pharm.D. Investigational Drug Service University of Washington Medical Center.
Hepatitis web study Hepatitis web study Interferon alfa-2b +/- Ribavirin for 24 or 48 weeks Phase 3 Treatment Naïve, Chronic HCV McHutchison JG, et al.
HealthStream Training for Postdoctoral Scholars involved in Clinical Research Linda S. Walker, Program Administrator Jessica P. Meyer, MBA, Program Coordinator.
INVESTIGATIONAL DRUG SERVICES IN THE HOSPITAL Sheree Miller, Pharm.D. University of Washington Medical Center
Indianapolis Discovery Network for Dementia Comparative Effectiveness Research Trial of Alzheimer’s Disease Drugs: COMET-AD.
Clinical Trials. What is a clinical trial? Clinical trials are research studies involving people Used to find better ways to prevent, detect, and treat.
Overview of the Clinical Trial & Protocol Jane Fendl March 31, 2010
Merrell Lim, Pharm.D. Investigational Drug Services Pharmacist
Yesterday, today, and tomorrow
Testing People Scientifically.  Clinical trials are research studies in which people help doctors and researchers find ways to improve health care. Each.
Jasper Ogwal-Okeng Gulu University Research Workshop 3 rd -6 th March 08.
Diabetes Clinical and Translational Research: Rewards and Challenges Ruth S. Weinstock MD PhD Medical Director, Joslin Diabetes Center and Clinical Research.
What is a Clinical Trial (alpha version) John M. Harris Jr., MD President Medical Directions, Inc.
Office of Clinical Research and Innovative Care Compliance (OCRICC) What You Need To Know About Conducting Research at Froedtert Hospital Roberta Navarro,
The Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Brief Protocol Training NIH-NINDS U01 NS NETT CCC U01 NS NETT SDMC U01 NS
Investigational Drugs in the hospital. + What is Investigational Drug? Investigational or experimental drugs are new drugs that have not yet been approved.
The Diabetic Retinopathy Clinical Research Network
Budget Development Presented by: Jean Mercer Associate Director for Clinical Research Administration Office of Clinical Research – School of Medicine.
1 Research Subject Registration & Grant Charges Clinical Research Education Series August 29 th, 2006 Marta Sears.
DRAFT SLIDES FOR NDA ADVISORY COMMITTEE PRESENATIONS.
CLINICAL TRIALS – PHASE III. What are phase III trials  Confirmatory phase (Therapeutic confirmatory trial)  Trials are done to obtain sufficient evidence.
1 SNDA Gemzar plus Carboplatin Treatment of Late Relapsing Ovarian Cancer.
Laser-Ranibizumab-Triamcinolone for DME Study DRCR.net Protocol I
Phase II in Second Line NSCLC DefinitionPhase II: BI 6727 vs. BI 6727+pemetrexed vs. pemetrexed in second line advanced NSCLC Early stopping.
The COMBINE Study: Design and Methodology Stephanie S. O’Malley, Ph.D. for The COMBINE Study Research Group JAMA Vol. 295, , 2006 (May 3 rd.
BASED ON PROTOCOL VERSION 1 SEPTEMBER 2012 A new study evaluating an investigational drug to treat patients with HER2-positive metastatic gastroesophageal.
The New Drug Development Process (www. fda. gov/cder/handbook/develop
بسم الله الرحمن الرحيم جامعة أم درمان الإسلامية كلية الطب و العلوم الصحية - قسم طب المجتمع مساق البحث العلمي / الدفعة 21 Basics of Clinical Trials.
JCRI Business Operations – Post-Award. Processes relating to the collection of sponsored clinical trial funding.
INPULSIS® trial design and baseline characteristics
How to Start An Industry Sponsored Clinical Trial
CTMB Guidelines (Rev. October 2006) Section 5: Conducting the Quality Assurance Audit.
1 EFFICACY OF SHORT COURSE AMOXICILLIN FOR NON-SEVERE PNEUMONIA IN CHILDREN (Hazir T*, Latif E*, Qazi S** AND MASCOT Study Group) *Children’s Hospital,
Copenhagen University Hospital Rigshospitalet, Denmark
SNDA Letrozole (Femara®) Indication: First-line therapy in post- menopausal women with advanced breast cancer. Prior approval: Second-line therapy.
Study Development and Design Suzanne Adams RN MPH Director, Clinical Operations Jefferson Clinical Research Institute.
DIVISION OF REPRODUCTIVE AND UROLOGIC PRODUCTS Clinical Trial Design Issues Phill Price MD.
Sponsor Visits and Monitoring
Agency Review of sNDA SE-006 DOXIL for Ovarian Cancer Division of Oncology Drug Products Office of Drug Evaluation 1 Center for Drug Evaluation.
Clinical Trials - PHASE II. Introduction  Important part of drug discovery process  Why important??  Therapeutic exploratory trial  First time in.
Making Clinical Trials More Efficient Site Management Organization (SMO)
Study Development and Design Suzanne Adams RN MPH Director, Clinical Operations Jefferson Clinical Research Institute.
Sponsor Visits and Monitoring Barbara Gallagher, RN Clinical Research Nurse Jefferson Clinical Research Institute.
CLINICAL TRIALS.
Clinical Trial Budgets
PRCSG Training Webinar: Budget for Industry Sponsored Studies
Introduction Review and proper registration of Human Gene Transfer protocols is very complex. A protocol goes through rigorous review by multiple Committees.
The Role and Responsibilities of the Clinical Research Coordinator
Clinicaltrials.gov Update
Clinical Trials – Industry Sponsored Budgets
Alcohol, Other Drugs, and Health: Current Evidence
Structure of Industry Budgets
Bozeman Health Clinical Research
Clinical Trials Budgeting
Getting a Study Done at Jefferson:
Clinical Trials Budgeting, Part 2
Cindy Murray NP Princess Margaret Cancer Centre
Intervista a Filippo de Marinis
Clinical Trial Budgets
Clinical Trial Budgets
Presentation transcript:

1 SPCTRM Stanford/Packard Center for Translational Research in Medicine SARP Meeting 7/24/08 Study Budgeting Anna Hu, RN, MPH Stanford University School of Medicine

SPCTRM website  SPCTRM calendar: /index.html /index.html  General Orientation  Budgeting and Billing Training  Workshops 2

3 Case Study I-Federally sponsored, multi- site, investigator initiated study conducted on CTRU (GCRC)  Study population: age > or = 18  Study design: Phase IV, 12 week DB, controlled trial  Will receive 1 injection weekly for 12 weeks  Evaluated monthly for safety and efficacy  Week 12 study therapy will be discontinued; subjects will be unblinded & returned to their MD for ongoing care  Week 16 safety f/u visit

Study Treatment  1 SQ injection of 40 mg OR 1 SQ injection of placebo in a blinded and alternating fashion for 12 weeks  1 SQ of 50 mg in a blinded fashion every week for 12 weeks 4

Endpoints- Efficacy  Change in DAS(CRP)28 score from baseline to week 12  Proportion of subjects achieving each separately at week 12 -DAS(CRP)28 value < or = 3.2 (low disease activity) -DAS(CRP)28 value < 2.6 (remission) 5

6 Schedule of Events

7 Where to begin? Review Protocol and Schedule of Events Assess feasibility of protocol (staffing, resources, can CTRU accommodate?) SPCTRM website: Clinical & Translational Research Planning (CTRP) Workbooks:

Demo of CTRP workbook  Clinical & Translational Research Planning (CTRP) Workbooks: Clinical & Translational Research Planning (CTRP) Workbooks:  Identify Research Tests/Procedures and Service Codes  Estimate Staff Effort (PI/Co-PI, CRC)  Work w/ your assigned RPM on finalizing budget 8

9  IRB IRB al/medical.html  RMG/Budget Specialist: Who is your RPM? “Sponsored” (Industry, NIH, Foundation) Research Only:  OSR/Contracts Officers by Dept: hortlist.xls

10 CTRU-Clinical & Translational Research Unit (formerly known as GCRC)-  html html 

11 CTRU (cont’d)  Protocol Application Information & Fees  Stanford GCRC Laboratory -

Research Pharmacy- Investigational Drug Services (IDS)  Protocol  Investigational Brochure  Set up & Dispensing Fees 12

13 Ancillary Services SHC/LPCH Clinical Laboratory  SHC/LPCH Clinical Labs Study Protocol Form-  orms/Study%20Protocol%20Form% %20doc2.doc orms/Study%20Protocol%20Form% %20doc2.doc

IRB approved/Budget finalized  CTRP workbook (RPS & Routine Care forms finalized)  Complete Study Account Request Form (98 account)  Requires PTA# from dept finance person  entire CTRP workbook to PFS  PFS will workbook back to you password protected 14

Begin enrolling study pts  Complete Study Enrollment Form with study pt info PRIOR to obtaining any services from the hospital  Indicates to PFS that your pt is a part of your study  If not completed in a timely manner-pt insurance will be billed & weekly report will not include your pt’s study charges 15

Example of Weekly Report 16

Weekly Report (cont’d) 17

Case Study II- Industry Sponsored  Phase III  Duration of study: 24 months  Primary Objective: compare the efficacy of 2 therapeutic regimens of “X” 800 mg TID PO in combo w/ 1.5 “P” SC & weigh based dosing of “R” PO to therapy in previously untreated adult subjects w/ chronic Hepatitis C 18

Case Study II (cont’d)  Subjects > or = 18 years of age  Subjects will be randomized in the three treatment arms in a 1:1:1 ratio by IVRS  All subjects will initiate therapy with 4 weeks of “P” + “R” treatment (“lead-in period”). 19

Case Study II (cont’d)  After the 4 week lead-in period, “X” or placebo will be added, based upon arm to which the subject is randomized.  At the end of treatment all subjects will enter follow-up, whose length will vary depending on the arm to which they were randomized. 20

Schedule of Events  Screening Evaluations: IC, I/E criteria, VS, Demo, MH, PE, AEs, Con Meds, Liver Biopsy, Ultrasound, Chest X-ray (PA/LAT), 12 Lead ECG, Ocular Exam 21

Lab Evaluations  Hematology, PT/PTT, AFP, ANA, Blood Chemistry, TSH, Serum Pregnancy, HCV-RNA PCR/HCV Genotype, Urine Drug Screen  CTRP workbook -drop-down list  Lab Test Directory: e/search.aspx e/search.aspx 22

Treatment Visit Schedule  Clinical Evaluations: I/E, VS, PE, AEs, Con Meds, Call IVRS, Study Med Dispensing & Drug Accountability, Dosing Diary Review, Subject Telephone Contact  Lab Evaluations: Hematology, PT/PTT, Blood Chemistry, TSH, Serum/Urine Pregnancy, HCV-RNA PCR/HCV Sequence Analysis, Urine Drug Screen 23

Tx visit schedule (cont’d)  Other Evaluations: (optional) Pharmacogenomics/Interferon Response Assay ICF, Interferon Response Assay Sample, Pharmacogenomics Sample, Health Status Evaluation Questionnaire 24

Follow-up Visit Schedule  Clinical Evaluations: VS, PE, AEs, Con Meds  Lab Evaluations: Hematology, PT/PTT, Blood Chemistry, TSH, Serum Pregnancy, HCV-RNA PCR/HCV Sequence Analysis, Urine Drug Screen  Other Evaluations: Health Status Evaluation Questionnaire 25

Next Steps:  Complete CTRP workbook (RPS & Routine Care Forms)  Work w/ your CT RPM on finalizing tests/procedures & service codes  IRB/Budget/Contract Finalized; NOA issued  Obtain PTA# from dept finance person  Complete Study Account Request Form  Send workbook to PFS 26

Next Steps (cont’d)  Obtain 98 account from PFS  Update workbook (Study Enrollment Form) PRIOR to study pt acquiring any study related tests/procedures from the hospital  Review Weekly Reports (hospital & pro fees)  Make any corrections and return to PFS 27

Points to Consider  CTRP workbook is a requirement to begin budgeting process for ANY clinical research involving patient care (incl. obtaining research pricing REGARDLESS of funding source)  Completing the CTRP workbook (ALL info on all tabs) is a requirement to obtain a 98 and/or LPCH research account 28

Points to Consider (cont’d)  Need to itemize all tests/procedures incl. service/cpt codes on RPS form in order to charge to a research account  Need to obtain PTA# from dept finance person in order to initiate 98 account  Need to complete Study Enrollment Form or else your patient/insurance will be billed 29

Points to Consider (cont’d)  Completing the study enrollment form ensures your research pt charges will show up on weekly billing reports  2 separate weekly reports 1) hospital and 2) pro fees only  Other Study Forms may apply-check SPCTRM website under Study Forms 30

31 Questions/Answers? SPCTRM X Anna Hu, RN, MPH X